IP Library Granted Patent US 12,391,988
Granted Patent B2
US 12,391,988 · App. 18/958,854 · Granted Aug 19, 2025

Sequencing a target sequence in a cell

Inventors: Andrew Pawlowski (San Diego, CA); Yeoan Youn (San Diego, CA); Michael Lawson (Pasadena, CA); Martin Maria Fabani (Encinitas, CA)
Assignee: Singular Genomics Systems, Inc.
C12Q1/6874C12Q1/25C12Q1/6841C12Q1/6862G01N2333/9015
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,391,988
App. No.
18/958,854
Filed
Nov 25, 2024
Granted
Aug 19, 2025
Kind
B2
Art Unit
1681
USPC
435/6.11
Abstract

Disclosed herein, inter alia, are methods for sequencing a target sequence in a cell by forming a circular oligonucleotide that incorporates a complement of the target sequence.

Claims (25)

1. A method of detecting a nucleic acid molecule in a cell, said method comprising amplifying a target sequence of the nucleic acid molecule, wherein amplifying comprises:

contacting a target polynucleotide complex in a cell with a probe oligonucleotide, thereby forming a probe polynucleotide complex;

wherein the target polynucleotide complex comprises a blocking oligonucleotide bound to a first sequence of a target polynucleotide, wherein the blocking oligonucleotide comprises a first target binding sequence, a first curl sequence, a second curl sequence, and a probe binding sequence, wherein said first curl sequence is complementary to said second curl sequence, wherein said probe polynucleotide complex comprises the probe oligonucleotide bound to a second sequence of the target polynucleotide and bound to the probe binding sequence, and wherein the target sequence is between said first and second sequence;

extending the probe oligonucleotide along the target sequence with a polymerase to generate an extended probe strand comprising a complement of the target sequence, and joining said extended probe strand to the probe oligonucleotide binding sequence, thereby generating a circular oligonucleotide;

extending an amplification primer bound to the circular oligonucleotide with a strand-displacing polymerase, thereby generating an amplification product comprising multiple copies of the target sequence; and

sequencing the target sequence in said cell and sequencing the second curl sequence, or a complement thereof, thereby detecting the nucleic acid molecule.

2. The method of claim 1 , wherein sequencing comprises sequencing by synthesis, sequencing by hybridization, sequencing by binding, or sequencing by ligation.

3. The method of claim 1 , wherein sequencing comprises hybridizing a sequencing primer to said amplification product, (a) extending the sequencing primer by incorporating a labeled nucleotide or labeled nucleotide analogue and (b) detecting the label for each incorporated nucleotide or nucleotide analogue.

4. The method of claim 1 , wherein the cell is permeabilized and immobilized to a solid support.

5. The method of claim 1 , wherein the first curl sequence is complementary to a sequence of the target polynucleotide.

6. The method of claim 1 , wherein the first curl sequence is about 4 to 15 nucleotides.

7. The method of claim 1 , wherein the blocking oligonucleotide comprises a modified nucleotide.

8. The method of claim 7 , wherein the modified nucleotide comprises a retarding moiety covalently bound to the modified nucleotide.

9. The method of claim 1 , wherein the first target binding sequence comprises locked nucleic acids (LNAs), Bis-locked nucleic acids (bisLNAs), twisted intercalating nucleic acids (TINAs), bridged nucleic acids (BNAs), 2′-O-methyl RNA:DNA chimeric nucleic acids, minor groove binder (MGB) nucleic acids, morpholino nucleic acids, C5-modified pyrimidine nucleic acids, peptide nucleic acids (PNAs), phosphorothioate nucleic acids, Zip nucleic acids (ZNAs), or combinations thereof.

10. The method of claim 1 , wherein the first target binding sequence comprises one or more locked nucleic acids (LNAs), Zip nucleic acids (ZNAs), 2-amino-deoxyadenosine (2-amino-dA), trimethoxystilbene-functionalized oligonucleotides (TFOs), Pyrene-functionalized oligonucleotides (PFOs), peptide nucleic acids (PNAs), or aminoethyl-phenoxazine-dC (AP-dC) nucleic acids.

11. The method of claim 2 , wherein the blocking oligonucleotide is the amplification primer, and amplifying comprises extending the probe binding sequence.

12. The method of claim 2 , wherein the target polynucleotide is the amplification primer.

13. The method of claim 1 , wherein the probe oligonucleotide further comprises a barcode sequence.

14. The method of claim 1 , wherein the target polynucleotide comprises RNA or cDNA.

15. The method of claim 1 , wherein the target polynucleotide comprises an IGH locus or a BCL-1, BCL-2, BCL-3, or BCL6 locus.

16. The method of claim 1 , wherein the target polynucleotide comprises a sequence encoding for a V region or a complement thereof and a J region or a complement thereof.

17. The method of claim 1 , wherein joining said extended probe strand to the probe oligonucleotide binding sequence comprises covalently binding adjacent sequences with a ligase.

18. The method of claim 17 , wherein the ligase is a pre-adenylated ligase.

19. The method of claim 17 , wherein the ligase is a PBCV-1 DNA Ligase.

20. The method of claim 17 , wherein the ligase is a TS2126 RNA ligase.

Assignments (2)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2024
From: PAWLOWSKI, ANDREW; YOUN, YEOAN; LAWSON, MICHAEL; FABANI, MARTIN MARIA
To: SINGULAR GENOMICS SYSTEMS, INC.
Reel/Frame 069511/0629 →
Continuity (3)
Continuation PCTUS2024032152 · May 31, 2024
Provisional Application 63505585 · Jun 1, 2023
Related Publication 20250115958A1 · Apr 10, 2025
References Cited (284)
US 4792520A · Stambrook et al. · 1988 [cited by applicant]
US 6218122B1 · Friend et al. · 2001 [cited by applicant]
US 6365367B1 · Friedman et al. · 2002 [cited by applicant]
US 7271952B2 · Suzuki et al. · 2007 [cited by applicant]
US 7390463B2 · He et al. · 2008 [cited by applicant]
US 8551710B2 · Bernitz et al. · 2013 [cited by applicant]
US 9371598B2 · Chee · 2016 [cited by applicant]
US 9556473B2 · Bernitz et al. · 2017 [cited by applicant]
US 9593365B2 · Frisen et al. · 2017 [cited by applicant]
US 9598723B2 · Ammann et al. · 2017 [cited by applicant]
US 10059990B2 · Boyden et al. · 2018 [cited by applicant]
US 10114015B2 · Glezer et al. · 2018 [cited by applicant]
US 10138509B2 · Church et al. · 2018 [cited by applicant]
US 10266888B2 · Daugharthy et al. · 2019 [cited by applicant]
US 10323272B1 · Rabbani et al. · 2019 [cited by applicant]
US 10495554B2 · Deisseroth et al. · 2019 [cited by applicant]
US 10774374B2 · Frisen et al. · 2020 [cited by applicant]
US 10841507B2 · Schürf et al. · 2020 [cited by applicant]
US 11155858B2 · Glezer et al. · 2021 [cited by applicant]
US 11434525B2 · Glezer · 2022 [cited by applicant]
US 11459603B2 · Tyagi et al. · 2022 [cited by applicant]
US 11486004B2 · Witters et al. · 2022 [cited by applicant]
US 11492662B2 · Glezer et al. · 2022 [cited by applicant]
US 11597965B2 · Nilsson et al. · 2023 [cited by applicant]
US 11643679B2 · Glezer et al. · 2023 [cited by applicant]
US 11680288B2 · Glezer · 2023 [cited by applicant]
US 11753678B2 · Glezer · 2023 [cited by applicant]
US 11891656B2 · Glezer et al. · 2024 [cited by applicant]
US 12006534B2 · Glezer · 2024 [cited by applicant]
US 12071667B2 · Bava et al. · 2024 [cited by applicant]
US 20010053519A1 · Fodor et al. · 2001 [cited by applicant]
US 20020064779A1 · Landegren et al. · 2002 [cited by applicant]
US 20030032024A1 · Lizardi et al. · 2003 [cited by applicant]
US 20030049862A1 · He et al. · 2003 [cited by applicant]
US 20030082556A1 · Kaufman et al. · 2003 [cited by applicant]
US 20030143536A1 · Lizardi · 2003 [cited by applicant]
US 20040137484A1 · Zhang et al. · 2004 [cited by applicant]
US 20050089860A1 · Arita · 2005 [cited by applicant]
US 20050130173A1 · Leamon et al. · 2005 [cited by applicant]
US 20050142556A1 · Hoon et al. · 2005 [cited by applicant]
US 20050208644A1 · Takiguchi et al. · 2005 [cited by applicant]
US 20050287526A1 · Landegren et al. · 2005 [cited by applicant]
US 20060050376A1 · Houston et al. · 2006 [cited by applicant]
US 20060166245A1 · Potter et al. · 2006 [cited by applicant]
US 20060292559A1 · Reddy et al. · 2006 [cited by applicant]
US 20090048119A1 · Krjutskov et al. · 2009 [cited by applicant]
US 20090263872A1 · Shannon et al. · 2009 [cited by applicant]
US 20090298718A1 · Denman et al. · 2009 [cited by applicant]
US 20110223585A1 · Gullberg et al. · 2011 [cited by applicant]
US 20120009629A1 · Becker et al. · 2012 [cited by applicant]
US 20120301886A1 · Farrell et al. · 2012 [cited by applicant]
US 20130296535A1 · Church et al. · 2013 [cited by applicant]
US 20140056811A1 · Jacob et al. · 2014 [cited by applicant]
US 20140057799A1 · Johnson et al. · 2014 [cited by applicant]
US 20140120534A1 · Bernitz et al. · 2014 [cited by applicant]
US 20140170654A1 · Landegren et al. · 2014 [cited by applicant]
US 20140256588A1 · Glezer et al. · 2014 [cited by applicant]
US 20150167092A1 · Kartalov et al. · 2015 [cited by applicant]
US 20150225778A1 · Hindson et al. · 2015 [cited by applicant]
US 20160108392A1 · Stelling · 2016 [cited by applicant]
US 20160116384A1 · Chen et al. · 2016 [cited by applicant]
US 20160145696A1 · Brandon et al. · 2016 [cited by applicant]
US 20160257993A1 · Fu et al. · 2016 [cited by applicant]
US 20160304952A1 · Boyden et al. · 2016 [cited by applicant]
US 20160369329A1 · Cai et al. · 2016 [cited by applicant]
US 20170067096A1 · Wassie et al. · 2017 [cited by applicant]
US 20170067925A1 · Spence et al. · 2017 [cited by applicant]
US 20170107563A1 · Samusik et al. · 2017 [cited by applicant]
US 20170343539A1 · Epstein et al. · 2017 [cited by applicant]
US 20180037943A1 · Rothwell et al. · 2018 [cited by applicant]
US 20180187242A1 · Makrigiorgos et al. · 2018 [cited by applicant]
US 20180223349A1 · Heller et al. · 2018 [cited by applicant]
US 20180246076A1 · Qian et al. · 2018 [cited by applicant]
US 20190017106A1 · Frisen et al. · 2019 [cited by applicant]
US 20190032121A1 · Daugharthy et al. · 2019 [cited by applicant]
US 20190055594A1 · Samusik et al. · 2019 [cited by applicant]
US 20190064109A1 · Brown et al. · 2019 [cited by applicant]
US 20190071668A1 · Schmidt et al. · 2019 [cited by applicant]
US 20190113423A1 · Goodman et al. · 2019 [cited by applicant]
US 20190119735A1 · Deisseroth et al. · 2019 [cited by applicant]
US 20190145982A1 · Chee et al. · 2019 [cited by applicant]
US 20190155835A1 · Daugharthy et al. · 2019 [cited by applicant]
US 20190161796A1 · Hauling et al. · 2019 [cited by applicant]
US 20190177718A1 · Church et al. · 2019 [cited by applicant]
US 20190194709A1 · Church et al. · 2019 [cited by applicant]
US 20190241950A1 · Daugharthy et al. · 2019 [cited by applicant]
US 20190258777A1 · Bo et al. · 2019 [cited by applicant]
US 20190264279A1 · Kain et al. · 2019 [cited by applicant]
US 20190376123A1 · Bobrow et al. · 2019 [cited by applicant]
US 20190391140A1 · Aghvanyan et al. · 2019 [cited by applicant]
US 20200032334A1 · Hubbell · 2020 [cited by applicant]
US 20200071751A1 · Daugharthy et al. · 2020 [cited by applicant]
US 20200087707A1 · Engreitz · 2020 [cited by applicant]
US 20200103639A1 · Skinner et al. · 2020 [cited by applicant]
US 20200124601A1 · Fan et al. · 2020 [cited by applicant]
US 20200140944A1 · Belgrader et al. · 2020 [cited by applicant]
US 20200224244A1 · Nilsson et al. · 2020 [cited by applicant]
US 20200224544A1 · Barker et al. · 2020 [cited by applicant]
US 20200271556A1 · Sarkar et al. · 2020 [cited by applicant]
US 20200277663A1 · Lyer et al. · 2020 [cited by applicant]
US 20200277664A1 · Frenz · 2020 [cited by applicant]
US 20200290043A1 · Williamson et al. · 2020 [cited by applicant]
US 20200294439A1 · Mandle et al. · 2020 [cited by applicant]
US 20200362334A1 · Regev et al. · 2020 [cited by applicant]
US 20200393477A1 · Davey et al. · 2020 [cited by applicant]
US 20210039062A1 · Mirkin et al. · 2021 [cited by applicant]
US 20210108195A1 · Bernate et al. · 2021 [cited by applicant]
US 20210164029A1 · Sekedat et al. · 2021 [cited by applicant]
US 20210164039A1 · Wang et al. · 2021 [cited by applicant]
US 20210189481A1 · Glezer et al. · 2021 [cited by applicant]
US 20210198727A1 · Kühnemund et al. · 2021 [cited by applicant]
US 20210222262A1 · Bakaher et al. · 2021 [cited by applicant]
US 20210238662A1 · Bava et al. · 2021 [cited by applicant]
US 20210238674A1 · Bava · 2021 [cited by examiner]
US 20210262018A1 · Bava et al. · 2021 [cited by applicant]
US 20210292834A1 · Daugharthy et al. · 2021 [cited by applicant]
US 20210318530A1 · Deissler · 2021 [cited by applicant]
US 20210333211A1 · Chen et al. · 2021 [cited by applicant]
US 20210363579A1 · Daugharthy · 2021 [cited by applicant]
US 20210382033A1 · Mir · 2021 [cited by applicant]
US 20210388424A1 · Bava · 2021 [cited by applicant]
US 20220042084A1 · Glezer · 2022 [cited by applicant]
US 20220112486A1 · Ramachandran Iyer et al. · 2022 [cited by applicant]
US 20220229044A1 · Feldman et al. · 2022 [cited by applicant]
US 20220333174A1 · Glezer et al. · 2022 [cited by applicant]
US 20220372570A1 · Costa · 2022 [cited by applicant]
US 20220403456A1 · Glezer et al. · 2022 [cited by applicant]
US 20220403457A1 · Glezer et al. · 2022 [cited by applicant]
US 20230027467A1 · Fredriksson · 2023 [cited by applicant]
US 20230031996A1 · Hernandez et al. · 2023 [cited by applicant]
US 20230037182A1 · Bava · 2023 [cited by examiner]
US 20230088043A1 · Kovacs et al. · 2023 [cited by applicant]
US 20230097368A1 · Glezer · 2023 [cited by applicant]
US 20230100215A1 · Glezer et al. · 2023 [cited by applicant]
US 20230203570A1 · Kovacs et al. · 2023 [cited by applicant]
US 20230279480A1 · Kühnemund · 2023 [cited by examiner]
US 20230357828A1 · Lezer · 2023 [cited by applicant]
US 20230366013A1 · Glezer · 2023 [cited by applicant]
US 20230374572A1 · Glezer · 2023 [cited by applicant]
US 20240026428A1 · Glezer et al. · 2024 [cited by applicant]
US 20240182956A1 · Glezer et al. · 2024 [cited by applicant]
US 20240287590A1 · Glezer · 2024 [cited by applicant]
US 20240360496A1 · Glezer · 2024 [cited by applicant]
JP 2005265627A · 2005 [cited by applicant]
JP 5970959B2 · 2016 [cited by applicant]
WO WO2005039389A2 · 2005 [cited by applicant]
WO WO2008042067A2 · 2008 [cited by applicant]
WO WO2013090360A2 · 2013 [cited by applicant]
WO WO2013090360A3 · 2013 [cited by applicant]
WO WO2014030066A2 · 2014 [cited by applicant]
WO WO2014030066A3 · 2014 [cited by applicant]
WO WO2017079382A1 · 2017 [cited by applicant]
WO WO2017143317A1 · 2017 [cited by applicant]
WO WO2018091676A1 · 2018 [cited by applicant]
WO WO2019068880A1 · 2019 [cited by applicant]
WO WO2019084062A1 · 2019 [cited by applicant]
WO WO2019195346A1 · 2019 [cited by applicant]
WO WO2019199579A1 · 2019 [cited by applicant]
WO WO2019222284A1 · 2019 [cited by applicant]
WO WO2020028194A1 · 2020 [cited by applicant]
WO WO2020076976A1 · 2020 [cited by applicant]
WO WO2020076979A1 · 2020 [cited by applicant]
WO WO2020096687A1 · 2020 [cited by applicant]
WO WO2020099640A1 · 2020 [cited by applicant]
WO WO2020102766A2 · 2020 [cited by applicant]
WO WO2020123309A1 · 2020 [cited by applicant]
WO WO2020160044A1 · 2020 [cited by applicant]
WO WO2022032194A1 · 2022 [cited by applicant]
WO WO2022032195A2 · 2022 [cited by applicant]
WO WO2022032195A3 · 2022 [cited by applicant]
WO WO2022235764A1 · 2022 [cited by applicant]
WO WO2023283090A1 · 2023 [cited by applicant]
WO WO2023076832A1 · 2023 [cited by applicant]
WO WO2023077109A1 · 2023 [cited by applicant]
WO WO2024182295A2 · 2024 [cited by applicant]
WO WO2024220013A1 · 2024 [cited by applicant]
WO WO2024249961A1 · 2024 [cited by applicant]
Agrawal, S. et al. (Nov. 15, 2016). “Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy,” [cited by applicant]
Ahern, H. (1995). “Biochemical, reagent kits offer scientists good return on investment,” [cited by applicant]
Alon, S. et al. (Jan. 19, 2021). “Expansion Sequencing: Spatially Precise In Situ Transcriptomics in Intact Biological Systems,” [cited by applicant]
Ambardar, S. et al. (Dec. 2016, e-published Jul. 9, 2016). “High throughput sequencing: an overview of sequencing chemistry,” [cited by applicant]
Arce, S. H. et al. (Jul. 24, 2013). “Fast and accurate automated cell boundary determination for fluorescence microscopy,” [cited by applicant]
Banér, J. et al. (Apr. 1, 2005). “Analysis of T-cell receptor vβ gene repertoires after immune stimulation and in malignancy by use of padlock probes and microarrays,” [cited by applicant]
Borkamo, E. D. et al. (Dec. 1, 2009, e-published Nov. 19, 2009). “cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy,” [cited by applicant]
Bullinger, L. et al. (Apr. 15, 2004). “Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia,” [cited by applicant]
Carow, B. et al. (Apr. 23, 2019). “Spatial and temporal localization of immune transcripts defines hallmarks and diversity in the tuberculosis granuloma,” [cited by applicant]
Carpenter, A. E. et al (Oct. 31, 2016). “CellProfiler: image analysis software for identifying and quantifying cell phenotypes,” [cited by applicant]
Catuogno, S. et al. (Apr. 8, 2011). “Recent advance in biosensors for microRNAs detection in cancer,” [cited by applicant]
Chen, F. et al. (Jan. 30, 2015, e-published Jan. 15, 2015). “Optical imaging. Expansion microscopy,” [cited by applicant]
Chen, K. H. et al. (Apr. 24, 2015, e-published Apr. 9, 2015). “RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells,” [cited by applicant]
Chen, X. et al. (Feb. 28, 2018, e-published Nov. 28, 2017). “Efficient in situ barcode sequencing using padlock probe-based BaristaSeq,” [cited by applicant]
Chen, X. et al. (Oct. 17, 2019). “High-throughput mapping of long-range neuronal projection using in situ sequencing,” [cited by applicant]
Christian, A. T. et al. (Dec. 4, 2001, e-published Nov. 27, 2001). “Detection of DNA point mutations and mRNA expression levels by rolling circle amplification in individual cells,” [cited by applicant]
Conze, T et al. (Jul. 2009, e-published Feb. 19, 2009). “Analysis of genes, transcripts, and proteins via DNA ligation,” [cited by applicant]
Costea, P. I. et al. (Mar. 4, 2013). “TagGD: fast and accurate software for DNA Tag generation and demultiplexing,” [cited by applicant]
Daigeler, A. et al. (Jul. 6, 2006). “Clinicopathological findings in a case series of extrathoracic solitary fibrous tumors of soft tissues,” [cited by applicant]
Denkert, C. et al. (Nov. 1, 2015, e-published Aug. 14, 2015). “Strategies for developing Ki67 as a useful biomarker in breast cancer,” [cited by applicant]
Edelman, M. J. et al. (May 1997, e-published Feb. 28, 2002). “The utility of follow-up testing after curative cancer therapy: a critical review and economic analysis,” [cited by applicant]
El-Sagheer, A. H. et al. (Aug. 21, 2012, e-published Mar. 22, 2012).“ Click nucleic acid ligation: applications in biology and nanotechnology,” [cited by applicant]
Extended European Search Report mailed Mar. 18, 2024, for EP Application No. 21852670.5, 13 pages. [cited by applicant]
Extended European Search Report mailed Mar. 28, 2024, for EP Application No. 21853956.7, 8 pages. [cited by applicant]
Fijnvandraat, A. C. et al. (Sep. 1, 2002, e-published Sep. 10, 2002). “Nonradioactive in situ detection of mRNA in ES cell-derived cardiomyocytes and in the developing heart,” [cited by applicant]
Frances-Soriano, L. et al. (Jan. 26, 2021, e-published Dec. 28, 2020). “In Situ rolling circle amplification Forster resonance energy transfer (RCA-FRET) for washing-free real-time single-protein imaging,” [cited by applicant]
Frank, D. N. (Oct. 29, 2009). “BARCRAWL and BARTAB: software tools for the design and implementation of barcoded primers for highly multiplexed DNA sequencing,” [cited by applicant]
Fredriksson, S. et al. (Apr. 2007, e-published Mar. 18, 2007). “Multiplexed protein detection by proximity ligation for cancer biomarker validation,” [cited by applicant]
Fredriksson, S. et al. (May 1, 2002). “Protein detection using proximity-dependent DNA ligation assays,” [cited by applicant]
Gao, H. et al. (Dec. 2019, e-published Oct. 17, 2019). “Rolling circle amplification for single cell analysis and in situ sequencing,” [cited by applicant]
Garmendia, C. et al. (Feb. 1992, e-published Feb. 5, 1992). “The bacteriophage phi 29 DNA polymerase, a proofreading enzyme,” [cited by applicant]
Gelali, E. et al. (Apr. 9, 2019). “iFISH is a publically available resource enabling versatile DNA FISH to study genome architecture,” [cited by applicant]
Gore, A. et al. (Mar. 3, 2011, e-published Mar. 2, 2011). “Somatic coding mutations in human induced pluripotent stem cells,” [cited by applicant]
Gullberg, M. et al. (May 21, 2004). “Cytokine detection by antibody-based proximity ligation,” [cited by applicant]
Guo, J. et al. (Jul. 8, 2008, e-published Jun. 30, 2008). “Four-color DNA sequencing with 3′-O-modified nucleotide reversible terminators and chemically cleavable fluorescent dideoxynucleotides,” [cited by applicant]
Gyllborg, D. et al. (Nov. 4, 2020). “Hybridization-based in situ sequencing (HybISS) for spatially resolved transcriptomics in human and mouse brain tissue,” [cited by applicant]
Hagai, T. et al. (Nov. 2018, e-published Oct. 24, 2018). “Gene expression variability across cells and species shapes innate immunity,” [cited by applicant]
Hamaday, M. et al. (Mar. 2008, e-published Feb. 10, 2008). “Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex,” [cited by applicant]
Hamilton, N. (Feb. 10, 2008) “Quantification and its applications in fluorescent microscopy imaging.” [cited by applicant]
Hardenbol, P. et al. (Jun. 1, 2003, e-published May 5, 2003) “Multiplexed genotyping with sequence-tagged molecular inversion probes.” [cited by applicant]
Heintzmann, R. et al. (Dec. 13, 2017, e-published Nov. 10, 2017). “Super-Resolution Structured Illumination Microscopy,” [cited by applicant]
Hu, Y. et al. (Sep. 3, 2014) “Sensitive quantification of messenger RNA with a real-time ligase chain reaction by using a ribonucleotide-modified DNA probe.” [cited by applicant]
International Search Report and Written Opinion mailed on Nov. 23, 2021, for PCT Application No. PCT/US2021/045104, filed Aug. 6, 2021, 15 pages. [cited by applicant]
International Search Report & Written Opinion mailed on Jan. 31, 2022, for PCT Application No. PCT/US2021/045105, filed Aug. 6, 2022, 18 pages. [cited by applicant]
International Search Report & Written Opinion mailed on Sep. 19, 2022, for PCT Application No. PCT/US2022/027630, filed May 4, 2022, 14 pages. [cited by applicant]
International Search Report and Written Opinion mailed on May 26, 2023 for PCT Application No. PCT/US2022/078941, filed Oct. 28, 2022, 16 pages. [cited by applicant]
International Search Report and Written Opinion mailed on Oct. 28, 2024 for PCT Application No. PCT/US2024/032152, filed May 31, 2024, 28 pages. [cited by applicant]
Jeong, S. et al. (Apr. 2020, e-published Jan. 30, 2020). “Current immunoassay methods and their applications to clinically used biomarkers of breast cancer,” [cited by applicant]
Kappler, K. et al. (Aug. 2020, e-published Aug. 5, 2020). “Emergence and significance of carbohydrate-specific antibodies,” [cited by applicant]
Ke, R. et al. (Sep. 2013, e-published Jul. 14, 2013) “In situ sequencing for RNA analysis in preserved tissue and cells,” [cited by applicant]
Klein A. M., et al. (Jul. 25, 2017). “InDrops and Drop-seq technologies for single-cell sequencing,” [cited by applicant]
Kobori, T. et al. (Jan. 2014) “Expanding possibilities of rolling circle amplification as a biosensing platform,” [cited by applicant]
Kohman, R. E. et al. (Apr. 28, 2020). “Fluorescent in situ sequencing of DNA barcoded antibodies,” [cited by applicant]
Krzywkowski, T. et al. (Oct. 2018). “Chimeric padlock and iLock probes for increased efficiency of targeted RNA detection,” [cited by applicant]
Lareau, C. A., et al. (Feb. 13, 2020). “Inference and effects of barcode multiplets in droplet-based single-cell assays,” [cited by applicant]
Larimore, K. et al. (Sep. 15, 2012). “Shaping of human germline IgH repertoires revealed by deep sequencing,” [cited by applicant]
Larsson, C. et al., (May 2010, e-published Apr. 11, 2010). “In situ detection and genotyping of individual mRNA molecules,” [cited by applicant]
Lee, J. H. et al. (Feb. 12, 2015). “Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues,” [cited by applicant]
Lee, J. H. et al. (Feb. 27, 2014, e-published Feb. 20, 2014). “Highly multiplexed subcellular RNA sequencing in situ,” Science 343(6177): 1360-1363. [cited by applicant]
Li, J. B. et al. (Sep. 2009, e-published Jun. 12, 2009). Multiplex padlock targeted sequencing reveals human hypermutable CpG variations, [cited by applicant]
Li, J. B. et al. (May 29, 2009). “Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing,” [cited by applicant]
Li, N. et al. (May 21, 2009). “Stand-alone rolling circle amplification combined with capillary electrophoresis for specific detection of small RNA.” [cited by applicant]
Lubeck, E. et al. (Jul. 2012, e-published Jun. 3, 2012). “Single-cell systems biology by super-resolution imaging and combinatorial labeling,” [cited by applicant]
Lubeck, E. et al. (Apr. 2014, e-published Mar. 28, 2014). “Single-cell in situ RNA profiling by sequential hybridization,” [cited by applicant]
Manuguerra I. et al. (May 1, 2018). “Gene assembly via one-pot chemical ligation of DNA promoted by DNA nanostructures,” [cited by applicant]
Mignardi, M. et al. (Apr. 28, 2014). “Fourth-generation sequencing in the cell and the clinic,” [cited by applicant]
Mitra, R.D. et al. (Sep. 1, 2003, e-published Jul. 15, 2003). “Fluorescent in situ sequencing on polymerase colonies.” [cited by applicant]
Mohammadi-Kambs, M. et al. (Apr. 30, 2017, e-published Apr. 5, 2017). “Hamming distance as a concept in DNA molecular recognition.” [cited by applicant]
Nilsson, M. et al. (Sep. 30, 1994). “Padlock probes: circularizing oligonucleotides for localized DNA detection,” [cited by applicant]
Nitta, H. et al. (Aug. 2013, e-published Nov. 15, 2015). “New methods for ALK status diagnosis in non-small-Cell lung Cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC—In situ hybrid… [cited by applicant]
Odeh, F. et al. (Dec. 18, 2019). “Aptamers Chemistry: Chemical Modifications and Conjugation Strategies,” [cited by applicant]
Ouladan, S. et al. (Jun. 2015, e-published Apr. 20, 2015). “Differential diagnosis of solitary fibrous tumors: A study of 454 soft tissue tumors indicating the diagnostic value of nuclear STAT6 relocation and ALDH1 expr… [cited by applicant]
Park, M. S. et al. (May 11, 2013). “The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis,” [cited by applicant]
Patel, A. P. et al. (Jun. 20, 2014, e-published Jun. 12, 2014). “Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma,” [cited by applicant]
Pearson, A. et al. (Aug. 2016, e-published May 13, 2016). “High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial,” [cited by applicant]
Peerzade, S. A. et al. (May 8, 2020). “Ultrabright Fluorescent Silica Nanoparticles for Multiplexed Detection,” [cited by applicant]
Peters, J. M. et al. (Jan. 1, 2011). “Multiparameter flow cytometry in the diagnosis and management of acute leukemia,” [cited by applicant]
Porreca, G. J. et al. (Nov. 2007, e-published Oct. 14, 2007). “Multiplex amplification of large sets of human exons,” [cited by applicant]
Rouhanifard, S. H., et al. (May 7, 2018) “Exponential fluorescent amplification of individual RNAs using clampFISH probes.” [cited by applicant]
Roussis, I. M. et al. (Mar. 3, 2017). “RNA whole-mount in situ hybridization proximity ligation assay (rISH-PLA), an assay for detecting RNA-protein complexes in intact cells,” [cited by applicant]
Sansone, A. (Jun. 2019, e-published May 30, 2019). “Spatial transcriptomics levels up,” [cited by applicant]
Sapoznik, E. et al. (Nov. 12, 2020). “A versatile oblique plane microscope for large-scale and high-resolution imaging of subcellular dynamics,” [cited by applicant]
Schallmeiner, E. et al. (Feb. 1, 2007, e-published Dec. 17, 2006). “Sensitive protein detection via triple-binder proximity ligation assays,” [cited by applicant]
Schlachter, S. et al. (Nov. 30, 2009). “A method to unmix multiple fluorophores in microscopy images with minimal a priori information,” [cited by applicant]
Shirakawa, H. et al. (Mar. 2004). “Blind spectral decomposition of single-cell fluorescence by parallel factor analysis,” [cited by applicant]
Söderberg, O. et al. (Dec. 2006, e-published Oct. 29, 2006). “Direct observation of individual endogenous protein complexes in situ by proximity ligation,” [cited by applicant]
Stratagene Catalog, The (1988). p. 39. [cited by applicant]
Strell, C. et al. (Apr. 2019, e-published Mar. 14, 2019). “Placing RNA in context and space-methods for spatially resolved transcriptomics,” [cited by applicant]
Suzuki, A. et al. (Dec. 20, 2019). “Characterization of cancer omics and drug perturbations in panels of lung cancer cells,” [cited by applicant]
Takahashi, H. et al. (May 17, 2018). “RNase H-assisted RNA-primed rolling circle amplification for targeted RNA sequence detection.” [cited by applicant]
Tang, S. et al. (Aug. 2, 2016). “Suppression of rolling circle amplification by nucleotide analogs in circular template for three DNA polymerases,” [cited by applicant]
Turczyk, B. M. et al. (Jul. 2020). “Spatial sequencing: a perspective,” [cited by applicant]
Vickovic, S. et al. (Oct. 2019, e-published Sep. 9, 2019). “High-definition spatial transcriptomics for in situ tissue profiling,” [cited by applicant]
Wang, G. et al. (Mar. 19, 2018). “Multiplexed imaging of high-density libraries of RNAs with MERFISH and expansion microscopy,” [cited by applicant]
Wang X. et al. (Jul. 27, 2018, e-published Jun. 21, 2018). “Three-dimensional intact-tissue sequencing of single-cell transcriptional states,” [cited by applicant]
Wassie, A. T. et al. (Dec. 20, 2018). “Expansion microscopy: principles and uses in biological research,” [cited by applicant]
Weibrecht, I. et al. (Jan. 24, 2013). “In situ detection of individual mRNA molecules and protein complexes or post-translational modifications using padlock probes combined with the in situ proximity ligation assay.” [cited by applicant]
Wilson, C. S. et al. (Jul. 15, 2006, e-published Apr. 4, 2006). “Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction,” [cited by applicant]
Xu, Q. et al. (Feb. 17, 2009). “Design of 240,000 orthogonal 25mer DNA barcode probes.” [cited by applicant]
York, A. G. et al. (Nov. 2013, e-published Oct. 6, 2013). “Instant super-resolution imaging in live cells and embryos via analog image processing,” [cited by applicant]
You, Y. et al. (Apr. 1, 2006, e-published Jan. 1, 2006). “Design of LNA probes that improve mismatch discrimination,” [cited by applicant]
Zhang, D. et al. (Jan. 2006, e-published Aug. 24, 2005). “Amplification of circularizable probes for the detection of target nucleic acids and proteins,” [cited by applicant]
Zhang, K. et al. (Aug. 2009, e-published Jul. 20, 2009). “Digital RNA allelotyping reveals tissue-specific and allele-specific gene expression in human,” [cited by applicant]
Zheng, G. X. et al. (Jan. 16, 2017). “Massively parallel digital transcriptional profiling of single cells,” [cited by applicant]
Iyer, E. P. R et al. (Mar. 20, 2018). “Barcoded oligonucleotides ligated on RNA amplified for multiplex and parallel in-situ analyses,” [cited by applicant]
Ke, R et al. (Sep. 2013) “In situ sequencing for RNA analysis in preserved tissue and cells.” [cited by applicant]
Lundin, E. et al. (Jan. 14, 2020). “Spatiotemporal mapping of RNA editing in the developing mouse brain using in situ sequencing reveals regional and cell-type-specific regulation,” [cited by applicant]